BARRETT & COMPANY, INC. - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 61 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARRETT & COMPANY, INC. ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$8,665
-5.4%
3,8340.0%0.00%0.0%
Q1 2024$9,163
+44.0%
3,8340.0%0.00%
+33.3%
Q4 2023$6,364
-33.5%
3,834
-23.1%
0.00%
-50.0%
Q3 2023$9,569
+33.3%
4,9840.0%0.01%
+50.0%
Q2 2023$7,177
-31.4%
4,9840.0%0.00%
-42.9%
Q1 2023$10,466
+85.8%
4,9840.0%0.01%
+75.0%
Q4 2022$5,6320.0%4,9840.0%0.00%0.0%
Q3 2022$5,6324,9840.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 89,240$255,0000.09%
BT Wealth Management LLC 57,009$163,0000.08%
HighVista Strategies LLC 30,200$86,0000.06%
D.A. DAVIDSON & CO. 840,948$2,405,0000.04%
Iron Gate Global Advisors LLC 17,090$49,0000.03%
Advisor Group, Inc. 799,846$2,287,0000.02%
Virtu Financial LLC 54,738$157,0000.02%
JOYN Advisors, Inc. 12,796$37,0000.01%
Vivaldi Capital Management LP 10,668$31,0000.01%
Ameritas Investment Company, LLC 10,782$31,0000.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders